Oncology meets digital health: The Paris-Saclay Cancer Cluster and Future4Care join forces to accelerate innovation

Paris, France, 06/19/2025

The Paris-Saclay Cancer Cluster (PSCC) and Future4Care have announced a strategic partnership to accelerate innovation in healthcare. This collaboration aims to enhance support for start-ups working at the crossroads of oncology and digital health by leveraging the strengths and networks of complementary ecosystems. 

As the need for transformative healthcare solutions continues to grow, the PSCC remains committed to translating world-class academic research into innovative therapeutic and diagnostic industrial solutions for cancer patients. Future4Care, a leading European ecosystem in Healthtech , brings together industry leaders and start-ups to develop cutting-edge digital solutions for tomorrow's healthcare system. 

A shared ambition to accelerate innovation in healthcare 

This collaboration is founded on a mutual commitment to supporting companies operating at the intersection of oncology and digital health. Through coordinated efforts, PSCC and Future4Care will provide startups with access to a wide range of complementary resources, including: 

• Cross-promotion of services and synergies across both ecosystems, with opportunities to participate in thematic sessions, co-organized events, and networking days hosted at each partner’s premises. 

• Enhanced visibility through joint communication initiatives, including social media campaigns, newsletters, and shared presence at key events. 

• Coordinated support for jointly accompanied startups, ensuring efficient resource allocation. 

• Priority access to PSCC and Future4Care facilities for eligible events organized as part of this partnership. 

Facilitating access to healthcare data 
Improving access to healthcare data is a shared priority for both PSCC and Future4Care, as it plays a key role in accelerating innovation. PSCC is currently developing a unified portal to simplify access to real-world data, in collaboration with leading hospital centers. At the same time, Future4Care supports startups and innovators in navigating the complex landscape of healthcare data and regulatory requirements. 

As part of their partnership, the two organizations will jointly launch surveys and working groups to better understand the needs of startups in oncology and e-health. They will also co-host thematic events focused on AI and data in oncology and co-develop tailored support tools and services for projects that align with both of their missions. 

"Through this partnership with Future4Care, we are significantly expanding the scope and quality of support we can offer to start-ups addressing oncology needs with digital health innovations," said Eric Vivier, President of the PSCC. "By combining our scientific and clinical expertise with Future4Care's strengths in digital innovation and industry partnerships, we are creating a seamless pathway for dual-domain projects. This collaboration will help accelerate the development of data-driven solutions that meet real clinical needs and ultimately improve patient outcomes." 

“At Future4care, we are firmly convinced that alliances between multidisciplinary players are key to shaping the future of healthcare, says Agnès de Leersnyder, CEO of Future4care. This is why we are delighted to partner with PSCC, whose mission and areas of expertise are highly complementary to our ecosystem. 
Together, we aim to foster new synergies for our members and help drive the success of innovative solutions that are already accelerating progress in oncology.  I’m looking forward to seeing the concrete projects that will emerge from this collaboration.” 

*** 

About the Paris-Saclay Cancer Cluster (PSCC) 

Founded by Gustave Roussy, Sanofi, Inserm, Institut Polytechnique de Paris, and Université Paris-Saclay, the PSCC is the first laureate of France 2030’s “Biocluster” call for projects. The PSCC is supported by startups, biotechs, and pharmaceutical companies and has already welcomed leading members such as UNICANCER, Institut Curie, AP-HP, and Medicen. 

The Cluster’s mission is to accelerate innovation in oncology and the development of new therapies, diagnostics, and medical devices in France. 
The PSCC supports project leaders at various stages of maturity by giving them access to the resources they need (expertise, platforms, services…) and by fostering strong collaboration among all stakeholders — researchers, experts, patients’ associations, clinicians, startups, industry players, investors — within a dynamic, high-potential ecosystem rooted in Villejuif. 

With an international outlook, the PSCC aims to position France as a global leader in transforming science into patient-focused solutions. 

🔗 parissaclaycancercluster.org 

About Future4care 

Future4care is a European ecosystem of multidisciplinary players dedicated to digital health. A joint venture founded in 2021 by the alliance of Capgemini, Generali, Orange and Sanofi, Future4care brings together E-health players (major groups, experts, healthcare professionals, startups, etc.) to create synergies and opportunities that will accelerate progress in digital healthcare. Since its launch, Future4care has brought together industrial and institutional partners, as well as qualified personalities from the scientific and cademic worlds within a Scientific and Ethical Council. 

🔗 https://future4care.com 

Contacts 

 Future4care : 

Justine Spitzer, head of Communications 

Justine@future4care.com 

06 88 85 36 60